PPARG and type 2 diabetes mellitus: The nuclear receptor peroxisome proliferator-activated receptor-γ (Pparg), which is a marker of increased adipogenesis in T2DM adipose tissue25, showed decreased expression after ENOblock treatment (Fig. 4L).